259 related articles for article (PubMed ID: 7896811)
41. Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase.
Cao J; Rehemtulla A; Pavlaki M; Kozarekar P; Chiarelli C
J Biol Chem; 2005 Mar; 280(12):10974-80. PubMed ID: 15637056
[TBL] [Abstract][Full Text] [Related]
42. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
[TBL] [Abstract][Full Text] [Related]
43. Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.
Knäuper V; Bailey L; Worley JR; Soloway P; Patterson ML; Murphy G
FEBS Lett; 2002 Dec; 532(1-2):127-30. PubMed ID: 12459476
[TBL] [Abstract][Full Text] [Related]
44. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
45. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells.
Huet E; Brassart B; Cauchard JH; Debelle L; Birembaut P; Wallach J; Emonard H; Polette M; Hornebeck W
Clin Exp Metastasis; 2002; 19(2):107-17. PubMed ID: 11964074
[TBL] [Abstract][Full Text] [Related]
46. Leukemic cells (HL-60) produce a novel extracellular matrix-degrading proteinase that is not inhibited by tissue inhibitors of matrix metalloproteinases (TIMPs).
Dittmann KH; Lottspeich F; Ries C; Petrides PE
Exp Hematol; 1995 Feb; 23(2):155-60. PubMed ID: 7828672
[TBL] [Abstract][Full Text] [Related]
47. Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases.
Hahn-Dantona E; Ramos-DeSimone N; Sipley J; Nagase H; French DL; Quigley JP
Ann N Y Acad Sci; 1999 Jun; 878():372-87. PubMed ID: 10415742
[TBL] [Abstract][Full Text] [Related]
48. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2).
Fridman R; Toth M; Peña D; Mobashery S
Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967
[TBL] [Abstract][Full Text] [Related]
49. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
50. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
Monea S; Lehti K; Keski-Oja J; Mignatti P
J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
[TBL] [Abstract][Full Text] [Related]
51. Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B.
Boon L; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Colau D; Gordon-Alonso M; van der Bruggen P; Stöcker W; Becker-Pauly C; Witters P; Morava E; Jaeken J; Proost P; Opdenakker G
FEBS J; 2019 Mar; 286(5):930-945. PubMed ID: 30422384
[TBL] [Abstract][Full Text] [Related]
52. Fluorescence quenching studies of matrix metalloproteinases (MMPs): evidence for structural rearrangement of the proMMP-2/TIMP-2 complex upon mercurial activation.
Stack MS; Itoh Y; Young TN; Nagase H
Arch Biochem Biophys; 1996 Sep; 333(1):163-9. PubMed ID: 8806767
[TBL] [Abstract][Full Text] [Related]
53. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G.
Okada Y; Nakanishi I
FEBS Lett; 1989 Jun; 249(2):353-6. PubMed ID: 2544455
[TBL] [Abstract][Full Text] [Related]
54. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin.
Sang QA; Bodden MK; Windsor LJ
J Protein Chem; 1996 Apr; 15(3):243-53. PubMed ID: 8804571
[TBL] [Abstract][Full Text] [Related]
55. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
Itoh Y; Nagase H
J Biol Chem; 1995 Jul; 270(28):16518-21. PubMed ID: 7622455
[TBL] [Abstract][Full Text] [Related]
56. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
Wang F; Reierstad S; Fishman DA
Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
[TBL] [Abstract][Full Text] [Related]
57. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen.
Moilanen M; Sorsa T; Stenman M; Nyberg P; Lindy O; Vesterinen J; Paju A; Konttinen YT; Stenman UH; Salo T
Biochemistry; 2003 May; 42(18):5414-20. PubMed ID: 12731883
[TBL] [Abstract][Full Text] [Related]
58. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
[TBL] [Abstract][Full Text] [Related]
59. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.
Shimada T; Nakamura H; Yamashita K; Kawata R; Murakami Y; Fujimoto N; Sato H; Seiki M; Okada Y
Clin Exp Metastasis; 2000; 18(2):179-88. PubMed ID: 11235994
[TBL] [Abstract][Full Text] [Related]
60. In vivo perimenstrual activation of progelatinase B (proMMP-9) in the human endometrium and its dependence on stromelysin 1 (MMP-3) ex vivo.
Rigot V; Marbaix E; Lemoine P; Courtoy PJ; Eeckhout Y
Biochem J; 2001 Aug; 358(Pt 1):275-80. PubMed ID: 11485578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]